Idera Pharmaceuticals Inc Stock Nasdaq
Equities
US45168K3068
Biotechnology & Medical Research
Financials (USD)
Sales 2021 | - | Sales 2022 | 4.86M | Capitalization | 3.12M |
---|---|---|---|---|---|
Net income 2021 | 98M | Net income 2022 | -23M | EV / Sales 2021 * | - |
Net cash position 2021 * | - | Net cash position 2022 * | - | EV / Sales 2022 * | - |
P/E ratio 2021 * |
-
| P/E ratio 2022 * |
-
| Employees | - |
Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 38.12% |
1st Jan change | Capi. | |
---|---|---|
+2.73% | 42.11B | |
+48.83% | 40.08B | |
+7.96% | 40B | |
-10.82% | 26.87B | |
+7.57% | 24.58B | |
-23.87% | 18.44B | |
+1.55% | 11.94B | |
+31.73% | 11.66B | |
+7.39% | 11.01B |